The two peptides operate through distinct, complementary mechanisms
The studied GLP-1 RAs included exenatide [14, 35, 37, 39], liraglutide [27, 36,37,38,39], semaglutide [27, 34, 37,38,39], lixisenatide [37, 39], dulaglutide [37, 39], albiglutide [39] and the dual agonist (GLP-1 and Glucose-dependent insulinotropic polypeptide (GIP)) tirzepatide [29, 37]
My results are amazing, and I conquered the biggest hurdle in this journey - picking the correct Doctor and team
Together, these effects help lower blood sugar levels and improve blood sugar control in people with type 2 diabetes
JAMA , 325(14), 1416-1425
Exploring the Combined Use Some doctors may mix them in some cases